High Quality Antiviral Agent, Monobenzone Cream, Whiten Skin Suppliers in China

Home > Products > Anti-Hiv Drug > Zlipin Lamivu Nevira Zidovu Tablet Anti-HIV

Zlipin Lamivu Nevira Zidovu Tablet Anti-HIV

Basic Info

Model No.:  A1609-1202A

Product Description

Model NO.: A1609-1202A

Usage Mode: For oral administration

State: Liquid

Type: Biological Products

Trademark: GUYENNE

Origin: France

Application: Internal Medicine

Suitable for: All

Shape: Capsules

Pharmaceutical Technology: Chemical Synthesis

Specification: 300mg

HS Code: 300290309

Product Description

Tablet 300mg for Anti HIV

Specification 300mg+150mg+200mg
Package 30tablets/bottle

Tenofovir disoproxil is an antiretroviral medication used to prevent and treat HIV/AIDS and to treat chronic hepatitis B. The active substance is tenofovir, while tenofovir disoproxil is a prodrug that is used because of its better absorption in the gut.

Medical uses

Tenofovir disoproxil fumarate (tenofovir DF) is a bioavailable prodrug of tenofovir, a potent nucleotide analogue reverse-transcriptase inhibitor with activity against human immunodeficiency virus (HIV) and hepatitis B virus. It is administered as a single 300-mg tablet once daily. It was approved for the treatment of HIV infection on the basis of data from clinical trials demonstrating activity in treatment-experienced patients, and it was subsequently shown to be effective when used as a component of initial therapy. Tenofovir DF is active against some nucleoside-resistant strains of HIV. However, cross-resistance is associated with multiple thymidine analogue mutations that include 41L or 210W. The signature mutation is the K65R mutation, which causes variable loss in susceptibility to tenofovir DF, . Tenofovir DF has been well tolerated in clinical trials with durations of follow-up up to 96 weeks. It is associated with more-favorable lipid profiles than and has not been associated with the mitochondrial toxicity attributed to other nucleoside analogues.

Tenofovir disoproxil fumarate (tenofovir DF) is an orally bioavailable prodrug of tenofovir. It is the first nucleotide analogue reverse-transcriptase inhibitor (NtRTI) to have been approved by the US Food and Drug Administration (FDA) for the treatment of HIV infection. Since its approval in October 2001, this analogue of adenine 5′ monophosphate has quickly become a widely used component of antiretroviral regimens for both treatment-naive and -experienced patients on the basis of its efficacy and tolerability in several clinical trials.

Contact us if you need more details on Tenofovir. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Disoproxil、Fumarate. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Anti-Hiv Drug

Email to this supplier
  • *Subject:
  • To:

  • *Messages:
    Your message must be between 20-8000 characters